161 related articles for article (PubMed ID: 31235445)
1. An improved treatment planning and quality assurance process for Collaborative Ocular Melanoma Study eye plaque brachytherapy.
Weersink RA; Patterson S; Ballantyne H; Di Tomasso A; Borg J; Vitkin A; Rink A; Beiki-Ardakani A
Brachytherapy; 2019; 18(5):658-667. PubMed ID: 31235445
[TBL] [Abstract][Full Text] [Related]
2. Improving quality assurance for assembled COMS eye plaques using a pinhole gamma camera.
Beiki-Ardakani A; Jezioranski J; Jaffray DA; Young I
Med Phys; 2008 Oct; 35(10):4318-23. PubMed ID: 18975677
[TBL] [Abstract][Full Text] [Related]
3. Delivered dose uncertainty analysis at the tumor apex for ocular brachytherapy.
Morrison H; Menon G; Larocque MP; Jans HS; Weis E; Sloboda RS
Med Phys; 2016 Aug; 43(8):4891. PubMed ID: 27487906
[TBL] [Abstract][Full Text] [Related]
4. Radio-luminescent imaging for rapid, high-resolution eye plaque loading verification.
Yan H; De Jean P; Grafil E; Ashraf R; Niedermayr T; Astrahan M; Mruthyunjaya P; Beadle B; Xing L; Liu W
Med Phys; 2023 Jan; 50(1):142-151. PubMed ID: 36183146
[TBL] [Abstract][Full Text] [Related]
5. Experimental validation of a new COMS-like 24 mm eye plaque for the treatment of large ocular melanoma tumors.
McCauley Cutsinger S; Forsman R; Corner S; Deufel CL
Brachytherapy; 2019; 18(6):890-897. PubMed ID: 31444131
[TBL] [Abstract][Full Text] [Related]
6. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
7. Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.
Miras H; Terrón JA; Lallena AM
Phys Med; 2013 Nov; 29(6):670-6. PubMed ID: 22858007
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo dosimetry of the eye plaque design used at the St. Erik Eye Hospital for (125)I brachytherapy.
Karlsson M; Nilsson J; Lundell M; Carlsson Tedgren A
Brachytherapy; 2014; 13(6):651-6. PubMed ID: 24950821
[TBL] [Abstract][Full Text] [Related]
9. Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.
Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
Med Phys; 2018 Jul; 45(7):3349-3360. PubMed ID: 29729009
[TBL] [Abstract][Full Text] [Related]
10. Investigating the dosimetric impact of seed location uncertainties in Collaborative Ocular Melanoma Study-based eye plaques.
Johnson JE; Deufel CL; Furutani KM
Brachytherapy; 2016; 15(5):661-8. PubMed ID: 27475484
[TBL] [Abstract][Full Text] [Related]
11. Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.
Gagne NL; Leonard KL; Rivard MJ
Med Phys; 2012 Jun; 39(6):3332-42. PubMed ID: 22755715
[TBL] [Abstract][Full Text] [Related]
12. An automated approach to seed assignment for eye plaque brachytherapy.
Koh TS; Yeung I; Tong S
Phys Med Biol; 2000 Jul; 45(7):1897-912. PubMed ID: 10943927
[TBL] [Abstract][Full Text] [Related]
13. A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using
Lee YC; Lin SC; Kim Y
Radiat Oncol; 2018 Nov; 13(1):221. PubMed ID: 30424782
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).
Acar H; Chiu-Tsao ST; Ozbay I; Kemikler G; Tuncer S
Med Phys; 2013 Jan; 40(1):011708. PubMed ID: 23298078
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy.
Knutsen S; Hafslund R; Monge OR; Valen H; Muren LP; Rekstad BL; Krohn J; Dahl O
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1159-66. PubMed ID: 11704341
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric study of the 15 mm ROPES eye plaque.
Granero D; Pérez-Calatayud J; Ballester F; Casal E; de Frutos JM
Med Phys; 2004 Dec; 31(12):3330-6. PubMed ID: 15651616
[TBL] [Abstract][Full Text] [Related]
17. Design and dosimetric considerations of a modified COMS plaque: the reusable "seed-guide" insert.
Astrahan MA; Szechter A; Finger PT
Med Phys; 2005 Aug; 32(8):2706-16. PubMed ID: 16193802
[TBL] [Abstract][Full Text] [Related]
18. A novel quality assurance system for eye plaque brachytherapy.
Kejda A; Cutajar D; Weaver M; Petasecca M; Rosenfeld A
Australas Phys Eng Sci Med; 2019 Dec; 42(4):1109-1115. PubMed ID: 31728937
[TBL] [Abstract][Full Text] [Related]
19. ROPES eye plaque brachytherapy dosimetry for two models of (103)Pd seeds.
Saidi P; Sadeghi M; Shirazi A; Tenreiro C
Australas Phys Eng Sci Med; 2011 Jun; 34(2):223-31. PubMed ID: 21452056
[TBL] [Abstract][Full Text] [Related]
20. Independent dosimetric assessment of the model EP917 episcleral brachytherapy plaque.
Aryal P; Molloy JA; Rivard MJ
Med Phys; 2014 Sep; 41(9):092102. PubMed ID: 25186402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
